These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28110554)

  • 1. Nebulized anionic guanidinylated O-carboxymethyl chitosan/N-2-hydroxypropyltimehyl ammonium chloride chitosan nanoparticles for siRNA pulmonary delivery: preparation, characterization and in vitro evaluation.
    Ni S; Xie Y; Tang Y; Liu Y; Chen J; Zhu S
    J Drug Target; 2017 Jun; 25(5):451-462. PubMed ID: 28110554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis of A549 cells by small interfering RNA targeting survivin delivery using poly-β-amino ester/guanidinylated O-carboxymethyl chitosan nanoparticles.
    Tang Y; Liu Y; Xie Y; Chen J; Dou Y
    Asian J Pharm Sci; 2020 Jan; 15(1):121-128. PubMed ID: 32175024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
    Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
    Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inhalable β₂-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung.
    Luo Y; Zhai X; Ma C; Sun P; Fu Z; Liu W; Xu J
    J Control Release; 2012 Aug; 162(1):28-36. PubMed ID: 22698944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-2'-hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine.
    Dai C; Kang H; Yang W; Sun J; Liu C; Cheng G; Rong G; Wang X; Wang X; Jin Z; Zhao K
    Carbohydr Polym; 2015 Oct; 130():280-9. PubMed ID: 26076628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary delivery.
    Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM
    Int J Pharm; 2013 Oct; 455(1-2):241-7. PubMed ID: 23876499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.
    Seifi-Najmi M; Hajivalili M; Safaralizadeh R; Sadreddini S; Esmaeili S; Razavi R; Ahmadi M; Mikaeili H; Baradaran B; Shams-Asenjan K; Yousefi M
    Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):87-94. PubMed ID: 27755958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing Mucosal Immune Response of Newcastle Disease Virus DNA Vaccine Using N-2-Hydroxypropyl Trimethylammonium Chloride Chitosan and N,O-Carboxymethyl Chitosan Nanoparticles as Delivery Carrier.
    Zhao K; Han J; Zhang Y; Wei L; Yu S; Wang X; Jin Z; Wang Y
    Mol Pharm; 2018 Jan; 15(1):226-237. PubMed ID: 29172532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA
    Ni S; Liu Y; Tang Y; Chen J; Li S; Pu J; Han L
    Carbohydr Polym; 2018 Jan; 179():135-144. PubMed ID: 29111036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunostimulatory effects of hydroxypropyltrimethyl ammonium chloride chitosan-carboxymethyl chitosan nanoparticles.
    Xu C; Xing R; Liu S; Qin Y; Li K; Yu H; Li P
    Int J Biol Macromol; 2021 Jun; 181():398-409. PubMed ID: 33781818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological evaluation of N-2-hydroxypropyl trimethyl ammonium chloride chitosan as a carrier for the delivery of live Newcastle disease vaccine.
    Zhao K; Sun Y; Chen G; Rong G; Kang H; Jin Z; Wang X
    Carbohydr Polym; 2016 Sep; 149():28-39. PubMed ID: 27261727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
    Gu J; Al-Bayati K; Ho EA
    Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of Fe
    Arami S; Rashidi MR; Mahdavi M; Fathi M; Entezami AA
    Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostimulatory effect of N-2-hydroxypropyltrimethyl ammonium chloride chitosan-sulfate chitosan complex nanoparticles on dendritic cells.
    Xu C; Xing R; Liu S; Qin Y; Li K; Yu H; Li P
    Carbohydr Polym; 2021 Jan; 251():117098. PubMed ID: 33142636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-stage development of novel cyclodextrin-siRNA nanocomplexes allows for successful postnebulization transfection of bronchial epithelial cells.
    Hibbitts A; O'Mahony AM; Forde E; Nolan L; Ogier J; Desgranges S; Darcy R; MacLoughlin R; O'Driscoll CM; Cryan SA
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):466-77. PubMed ID: 24665866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and testing of quaternized chitosan nanoparticles as gene delivery vehicles.
    Li GF; Wang JC; Feng XM; Liu ZD; Jiang CY; Yang JD
    Appl Biochem Biotechnol; 2015 Apr; 175(7):3244-57. PubMed ID: 25686559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Codelivery of mTERT siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumor suppression.
    Wei W; Lv PP; Chen XM; Yue ZG; Fu Q; Liu SY; Yue H; Ma GH
    Biomaterials; 2013 May; 34(15):3912-23. PubMed ID: 23453062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune enhancement of N-2-Hydroxypropyl trimethyl ammonium chloride chitosan/carboxymethyl chitosan nanoparticles vaccine.
    Gao Y; Gong X; Yu S; Jin Z; Ruan Q; Zhang C; Zhao K
    Int J Biol Macromol; 2022 Nov; 220():183-192. PubMed ID: 35981671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
    Khurana B; Goyal AK; Budhiraja A; Aora D; Vyas SP
    Drug Deliv; 2013 Feb; 20(2):57-64. PubMed ID: 23537464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.